key: cord-1031491-xqjy6zo5 authors: Moreno-Contreras, Joaquín; Espinoza, Marco A.; Sandoval-Jaime, Carlos; Cantú-Cuevas, Marco A.; Barón-Olivares, Héctor; Ortiz-Orozco, Oscar D.; Muñoz-Rangel, Asunción V.; Hernández-de la Cruz, Manuel; Eroza-Osorio, César M.; Arias, Carlos F.; López, Susana title: Saliva sampling is an excellent option to increase the number of SARS CoV2 diagnostic tests in settings with supply shortages date: 2020-07-01 journal: bioRxiv DOI: 10.1101/2020.06.24.170324 sha: 0805fbb59478df47dc43504852e461bf976e76f4 doc_id: 1031491 cord_uid: xqjy6zo5 As part of any plan to lift or ease the confinement restrictions that are in place in many different countries, there is an urgent need to increase the capacity of laboratory testing for SARS CoV-2. Detection of the viral genome through RT-qPCR is the golden standard for this test, however, the high demand of the materials and reagents needed to sample individuals, purify the viral RNA, and perform the RT-qPCR test has resulted in a worldwide shortage of several of these supplies. Here, we show that directly lysed saliva samples can serve as a suitable source for viral RNA detection that is cheaper and can be as efficient as the classical protocol that involves column purification of the viral RNA. In addition, it surpasses the need for swab sampling, decreases the risk of the healthcare personnel involved in this process, and accelerates the diagnostic procedure. With the worldwide COVID-19 health emergency, there is an urgent need for rapid and 31 reliable methods of diagnostic for SARS-CoV-2. The accepted golden standard for detection of 32 this virus is the amplification of regions of the viral genome by RT-qPCR in nasopharyngeal and 33 oropharyngeal swabs [1] [2]. Unfortunately, given the enormous demand of the reagents needed 34 to collect the biological samples, and to purify the viral RNA, there have been shortages of many 35 of the reagents needed for the diagnostic tests. Swabs, viral transport media, and kits for viral 36 RNA extraction are amongst the most common consumables that have become scarce, using the StarQ One-Step RT-qPCR (Genes 2 Life) kit, using 5 l of the column extracted total RNA 83 in a 20 l of reaction mix, or 2.5 l of the QE treated saliva into 22.5 l of reaction mix. Samples 84 were analyzed in an ABI Prism 7500 Sequence Detector System (Applied Biosystems) with the 85 following thermal protocol: 50ºC for 15 min, 95ºC for 2 min and then 45 cycles of 95ºC for 15 s 86 and 60ºC for 30 s. All samples with a Ct value equal or less than 38 were classified as positive. 87 Determination of viral copy number. To determine the viral copy number in a sample, a standard 88 curve was generated using a 10-fold serial dilution of an in vitro T7 RNA transcript that encodes 89 the sequence recognized by oligonucleotides and probe for gene E. Briefly, the logarithm of 90 . As an internal control of RNA content in the samples, the RNase P gene was detected. 106 Total RNA was purified from swabs using the QIAamp viral RNA mini kit; the RNA in saliva was 107 directly obtained using the QE lysis buffer (Lucigen) and boiling for 5 min, as reported [12] . 108 During the course of the study, and due to the shortage of swabs, the health center 109 were positive by testing the swabs (Table 1 and Fig. 1) . 126 127 Quantitation of viral RNA. When the number of viral genome copies in the single OPS and saliva 128 samples were compared, a significant difference in the geometric mean was detected, with saliva 129 samples having a 1.9 log10 higher titer than that observed in the swabs (p<0.0024, Fig. 2A ). This 130 can be better appreciated when the viral copy number in paired swabs and saliva from the same 131 patient, is plotted and represented as connecting lines ( higher Ct values of RNase P detected in these samples (Fig. 2C) , with the consequent low viral 159 copy number. This is a major concern, since the medical personnel in charge of taking the samples 160 frequently do not do it correctly for the risk associated with this process. It has been reported 161 that oropharyngeal swabs have a lower viral titer compared with nasopharyngeal swabs [2]; thus, 162 this could contribute to the discrepancies observed. Furthermore, it has also been previously 163 reported that nasopharyngeal swabs have a lower viral titer than saliva samples [13] , what can 164 also contribute to explain our findings. On the other hand, the false negatives in saliva could be 165 due to undetected problems during the collection, transport and or storage of the sample before 166 its arrival to the laboratory. Combination of RT-qPCR testing and clinical features 219 for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak Viral load of SARS-CoV-2 in clinical 222 samples Consistent detection of 2019 novel coronavirus 224 in saliva Saliva as a non-invasive 226 specimen for detection of SARS-CoV-2 Self-Collected oral fluid and nasal swabs demonstrate 229 comparable sensitivity to clinician collected nasopharyngeal swabs for Covid-19 detection COVID-19 and the Risk to Health Care Workers: A 232 Case Report Human Saliva: Non-Invasive Fluid for Detecting 234 Novel Coronavirus (2019-nCoV) Clinical features of patients infected with 2019 novel 237 coronavirus in Wuhan Clinical Characteristics of 138 Hospitalized Patients With 240 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Comparative Performance of SARS-CoV-2 243 Detection Assays Using Seven Different Primer-Probe Sets and One Assay Kit Genetic diversity among SARS-CoV2 strains in 246 South America may impact performance of Molecular detection A 5-min RNA preparation method for COVID-19 249 detection with RT-qPCR Saliva is more sensitive for SARS-CoV-2 252 detection in COVID-19 patients than nasopharyngeal swabs Comparison of SARS-CoV-2 detection in 255 nasopharyngeal swab and saliva Temporal profiles of viral load in posterior 258 oropharyngeal saliva samples and serum antibody responses during infection by SARS-259 CoV-2: an observational cohort study One-step RNA extraction for RT-qPCR detection of 262 The impact of viral transport media on PCR assay results for the 264 detection of nucleic acid from SARS-CoV-2 and other viruses Overcoming inhibition in real-time diagnostic PCR Detection of 2019 -nCoV by RT-PCR